You are here

Pfizer more than doubles price of Covid-19 medication Paxlovid, shortages in poorer countries

Primary tabs

The list price, before insurance, will be $1,390 for a five-day course, Pfizer said in a statement. That’s 2.6 times higher than the $530-per-course price paid by the US government, which provided Paxlovid free to patients during the pandemic. The Wall Street Journal first reported the new price.

Pfizer noted that the list price “does not necessarily reflect the price a patient will pay” and said it’s working to secure health insurance arrangements that would come with low out-of-pocket costs to patients. The company also said it would offer assistance with copays for people who qualify, which could bring their out-of-pocket costs to nothing.

...

ALSO SEE: Shortage of Paxlovidin Lower and Middle Income Countries  During COVID-19 Emergency

 

 

Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
howdy folks
Page loaded in 0.533 seconds.